Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?. Issue 11 (27th September 2018)

Record Type:: Journal Article
Title:: Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?. Issue 11 (27th September 2018)
Main Title:: Question 2: Etanercept or adalimumab: which is a better biological therapy for juvenile idiopathic arthritis?
Authors:: Hunter, Harriet
Abstract:
Is Part Of:: Archives of disease in childhood. Volume 103:Issue 11(2018)
Journal:: Archives of disease in childhood
Issue:: Volume 103:Issue 11(2018)
Issue Display:: Volume 103, Issue 11 (2018)
Year:: 2018
Volume:: 103
Issue:: 11
Issue Sort Value:: 2018-0103-0011-0000
Page Start:: 1087
Page End:: 1089
Publication Date:: 2018-09-27
Subjects:: rheumatology -- juvenile rheumatoid arthritis -- etanercept -- adalimumab
Children -- Diseases -- Periodicals
Infants -- Diseases -- Periodicals
618.920005
Journal URLs:: http://adc.bmjjournals.com/ ↗
http://www.bmj.com/archive ↗
DOI:: 10.1136/archdischild-2018-315528 ↗
Languages:: English
ISSNs:: 0003-9888
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 23066.xml